Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating B cell neoplasm

Details for Australian Patent Application No. 2006246897 (hide)

Owner Changchun Huapu Biotechnology Co., Ltd.

Inventors Wang, Li-Ying; Yu, Yong-Li; Bao, MuSheng

Agent Allens Arthur Robinson

Pub. Number AU-B-2006246897

PCT Pub. Number WO2006/122463

Priority 200510069576.4 17.05.05 CN

Filing date 13 February 2006

Wipo publication date 23 November 2006

Acceptance publication date 12 April 2012

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/117 (2010.01) Mutation or genetic engineering - Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

6 December 2007 PCT application entered the National Phase

  PCT publication WO2006/122463 Priority application(s): WO2006/122463

12 April 2012 Application Accepted

  Published as AU-B-2006246897

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006246898-An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating B cell neoplasm

2006246891-Administration device with forced priming